65 results
424B3
PTIX
Protagenic Therapeutics, Inc.
27 Dec 24
Prospectus supplement
4:00pm
competing products’ clinical trials;
time of year in which the trials are initiated or conducted;
severity of the diseases under investigation;
ability
8-K
EX-10.1
PTIX
Protagenic Therapeutics, Inc.
29 Oct 24
Protagenic Therapeutics Announces Pricing of Private Placement for Aggregate Gross Proceeds of $1.275 Million
9:52pm
of Arcadia Securities, LLC. “Proceeding” means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation … , there is no action, suit, inquiry, notice of violation, proceeding or investigation pending or, to the knowledge of the Company, threatened against or affecting
8-K
EX-10.2
PTIX
Protagenic Therapeutics, Inc.
29 Oct 24
Protagenic Therapeutics Announces Pricing of Private Placement for Aggregate Gross Proceeds of $1.275 Million
9:52pm
to each Holder, to conduct a reasonable investigation within the meaning of the Securities Act. The Company shall not file a Registration Statement … and effect regardless of any investigation made by or on behalf of such indemnified person and shall survive the transfer of any Registrable Securities
8-K
EX-1.1
293c 2dmxr9njdj
2 Jul 21
Entry into a Material Definitive Agreement
4:50pm
8-K
EX-1.1
tuzuezqbdwb
30 Apr 21
Protagenic Therapeutics, Inc. Announces Nasdaq Uplisting and Pricing of $13.2 Million Public Offering
3:19pm
424B4
dsue4nh
28 Apr 21
Prospectus supplement with pricing info
5:29pm
424B4
jyohj
28 Apr 21
Prospectus supplement with pricing info
5:29pm